Search Within

Dean Bajorin

Formats
  1. Journal Article (346)
  2. Meeting Abstract (283)
  3. Book Section (17)
  4. Correspondence (6)
  5. Conference Paper (5)
  6. Review (3)
  7. Book Whole (1)
  8. Editorial (1)
  9. Research Letter (1)
Groups
  1. Department of Medicine (663)
  2. Genitourinary Oncology Service (663)
  3. Solid Tumor Oncology Division (663)
  4. Surgery (283)
  5. Urology (273)
  6. Survivorship Research (233)

More Groups

People
  1. Jonathan Rosenberg (205)
  2. Gopakumar Iyer (164)
  3. Hikmat Al-Ahmadie (150)
  4. George Bosl (147)
  5. Bernard Bochner (141)
  6. David Solit (130)

More People

Years
  1. 2025 (12)
  2. 2024 (15)
  3. 2023 (17)
  4. 2022 (29)
  5. 2021 (32)
  6. 2020 (36)

More Years

Publications
  1. Journal of Clinical Oncology (270)
  2. Annals of Oncology (27)
  3. Cancer (26)
  4. Journal of Urology (25)
  5. Modern Pathology (19)
  6. Laboratory Investigation (18)

More Publications

Publishers
  1. American Society of Clinical Oncology (280)
  2. Elsevier Science, Inc. (59)
  3. Elsevier Inc. (51)
  4. American Association for Cancer Research (40)
  5. Wiley Blackwell (40)
  6. Oxford University Press (35)

More Publishers

Results (663)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comprehensive molecular characterization of urothelial bladder carcinoma
    Journal Article

    The Cancer Genome Atlas Research Network
    Nature (2014)

    Fulltext@MSK | Save
  • Highlights from the first symposium on upper tract urothelial carcinoma
    Journal Article

    Matin, S. F.; Shariat, S. F.; Milowsky, M. I.; Hansel, D. E.; Kassouf, W.; Koppie, T.; Bajorin, D.; Grollman, A. P.
    Urologic Oncology: Seminars and Original Investigations (2014)

    Fulltext@MSK | Save
  • The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer
    Journal Article

    Kim, P. H.; Kent, M.; Zhao, P.; Sfakianos, J. P.; Bajorin, D. F.; Bochner, B. H.; Dalbagni, G.
    World Journal of Urology (2014)

    Fulltext@MSK | Save
  • Clinical trial design for the development of new therapies for nonmuscle-invasive bladder cancer: Report of a food and drug administration and american urological association public workshop
    Journal Article

    Jarow, J. P.; Lerner, S. P.; Kluetz, P. G.; Liu, K.; Sridhara, R.; Bajorin, D.; Chang, S.; Dinney, C. P. N.; Groshen, S.; Morton, R. A.; more...
    Urology (2014)

    Fulltext@MSK | Save
  • Prediction of pathologic complete response to neoadjuvant chemotherapy in urothelial cancer by genetic determinants of platinum sensitivity
    Meeting Abstract

    O'Donnell, P. H.; Alanee, S.; Cao, H.; Ostrovnaya, I.; Garcia-Grossman, I. R.; Ganshert, C.; Smith, N. D.; Steinberg, G. D.; Offit, K.; Stadler, W. M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Long-term survival rates after chemotherapy (CTx) in patients (pts) with nonseminomatous (NS) germ cell tumors (GCT) with teratoma (T)
    Meeting Abstract

    Patil, S.; Feldman, D. R.; Bajorin, D. F.; Motzer, R. J.; Sheinfeld, J.; Tickoo, S.; Reuter, V. E.; Bosl, G. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • HER2 expression in patients (pts) with surgically resected urothelial cancer at high risk of recurrence screened for the phase II randomized, open-label trial of DN24-02, an autologous cellular immunotherapy targeting HER2
    Meeting Abstract

    Press, M. F.; O'Donnell, P. H.; Plimack, E. R.; Gomella, L. G.; Quinn, D. I.; Sharma, P.; DeVries, T.; Sims, R. B.; Chen, M.; Bajorin, D. F.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Final results of a multicenter, open-label phase II trial of dovitinib (TKI258) in patients with advanced urothelial carcinoma with either mutated or nonmutated FGFR3
    Meeting Abstract

    Milowsky, M. I.; Dittrich, C.; Martinez, I. D.; Jagdev, S.; Millard, F. E.; Sweeney, C.; Bajorin, D. F.; Cerbone, L.; Dunn, R. M.; Sen, P.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II trial of paclitaxel, ifosfamide, and cisplatin (TIP) for previously untreated patients (pts) with intermediate- or poor-risk germ cell tumors (GCT)
    Meeting Abstract

    Feldman, D. R.; Hu, J.; Dorff, T. B.; Patil, S.; Van Alstine, L. J.; Momen, L.; Carousso, M.; Hughes, A.; Snively-Solomon, J.; Ketchens, C.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Exome sequencing of extreme phenotypes to identify variants predictive of response to chemotherapy in bladder cancer
    Meeting Abstract

    Alanee, S.; Shah, S.; Stratton, K. L.; Garcia-Grossman, I. R.; Zabor, E.; Ostrovnaya, I.; Joseph, V.; Pendse, D.; Bajorin, D. F.; Offit, K.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save